CP-316819, CAS [[186392-43-8]]

Product Overview

• Article Name: CP-316819, CAS [[186392-43-8]]
• Biozol Catalog Number: MCE-HY-108615
• Supplier Catalog Number: HY-108615
• Alternative Catalog Number: MCE-HY-108615-5MG,MCE-HY-108615-10MG,MCE-HY-108615-25MG,MCE-HY-108615-100MG,MCE-HY-108615-50MG,MCE-HY-108615-10MMX1ML
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: GPi 819

Product Description

CP-316819 (GPi 819) is a blood-brain barrier permeable glycogen phosphorylase inhibitor. CP-316819 inhibits hepatic glycogenolysis, safely reduces blood glucose in type 2 diabetes, and rarely induces hypoglycemia. CP-316819 increases brain glycogen reserves, protects neurons, alleviates hypoglycemic brain injury, and inhibits excessive platelet activation, exerting both neuroprotective and vasculoprotective effects. CP-316819 can be used in research related to hypoglycemia, thrombosis, autoimmune inflammatory diseases, and type 2 diabetes[1][2][3][4].

Product Properties

• Molecular Weight: 415.87
• Purity: 99
• CAS Number: [186392-43-8]
• Formula: C21H22ClN3O4
• Target: Phosphorylase

Application Notes

• Application Notes: MCE Product type: Reference compound